… announced that the Committee for Medicinal Products for Human Use (CHMP … for infusion), its trastuzumab biosimilar, for the treatment of HER2-positive metastatic … range of products from bulk drug substance to fill-finish and …

… / vanzacaftor), a medicine intended for the treatment of cystic fibrosis in … pre-clinical tests and clinical trials of an already-authorised reference … opinions for nine biosimilar medicines: Dazublys (trastuzumab), for the treatment of metastatic and …

… Drug Administration in 2017 for the extended adjuvant treatment … FDA in combination with capecitabine for the treatment … trastuzumab-based therapy. NERLYNX® is a registered trademark of Puma Biotechnology … trial of alisertib monotherapy for the treatment …

… in the Department of Medical Oncology and Therapeutics Research … treatment options based on findings from the SUNLIGHT trial … the lookout for clinical trials to improve outcomes. REFERENCES … et al. FDA approval summary: tucatinib with trastuzumab for advanced …

… Jazz Pharmaceuticals) marks a pivotal moment in the treatment of … -targeted therapies, such as trastuzumab (Herceptin; Roche) or pertuzumab … in addressing an unmet medical need. Zanidatamab is … ;/www.accessdata.fda.gov/drugsatfda_docs/label…

… commercializes high quality medicines for the treatment of oncology, … 1 combined with either trastuzumab (HER-2 positive) … from investigator-initiated clinical trials (IIT), except one abstract … that first-rate pharmaceutical drugs can become widely accessible …

Extended treatment with pyrotinib in the adjuvant setting following trastuzumab (Herceptin)-based adjuvant … from the phase 2 PERSIST trial (NCT05880927). At a median follow … was an investigator-initiated, exploratory trial that enrolled patients 18 to …

… approved by the FDA in 2019 for the adjuvant treatment of patients … neoadjuvant taxane and trastuzumab-based treatment.2 Similar to other treatments, resistance remains … only help overcome resistance to drugs like trastuzumab and lapatinib but also …

… in the LUX-Lung trials and erlotinib benefiting … limited-stage SCLC.4 Trastuzumab deruxtecan (Enhertu; Daiichi-Sankyo … in the CheckMate 227 trial.10 Together, these … treatments advance, targeted therapies are shifting care toward personalized medicine. …

… based chemotherapy. These trials include AVANZAR, NeoCOAST … of each trial. The experimental medications, Oleclumab, … treatment landscape of HER2-mutant non-small cell lung cancer: trastuzumab … inhibitor-based antibody-drug conjugates. Pharmaceutics. 2022;14 …